                         SEQUENCE LISTING

<110>  THE REGENTS OF THE UNIVERSITY OF MICHIGAN
 
<120>  CRYSTALLINE POLYMORPHIC FORMS OF STING AGONISTS ASSOCIATED WITH 
       METAL IONS CAPABLE OF MODULATING AN IMMUNE RESPONSE

<130>  UM-38858-601

<150>  US 63/092,295
<151>  2020-10-15

<160>  27    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  1

Glu Glu Val Val Ala Cys 
1               5       


<210>  2
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  2

Ser Asp Lys Pro 
1               


<210>  3
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  3

Cys Gly Tyr Gly Pro Lys Lys Lys Arg Lys Val Gly Gly 
1               5                   10              


<210>  4
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  4

Asp Asp Asp Asp Asp 
1               5   


<210>  5
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  5

Asp Asp Asp Asp Asp Asp 
1               5       


<210>  6
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  6

Asn Pro Asn Ala Asn Pro Asn Ala 
1               5               


<210>  7
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  7

Val Ala Ile Thr Val Leu Val Lys 
1               5               


<210>  8
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  8

Val Gly Val Arg Val Arg 
1               5       


<210>  9
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  9

Val Ile His Ser 
1               


<210>  10
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  10

Val Pro Asp Pro Arg 
1               5   


<210>  11
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  11

Val Thr Cys Gly 
1               


<210>  12
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  12

Ser Cys Val Arg Ala Cys Gly Ala Asp Ser Tyr Glu Met Glu Glu Asp 
1               5                   10                  15      


Gly Val Arg Lys 
            20  


<210>  13
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  13

Val Trp Ser Tyr Gly Val Thr Val Trp Glu Leu Met Thr Phe Gly Ser 
1               5                   10                  15      


Lys Pro Tyr 
            


<210>  14
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  14

Arg Met Phe Pro Asn Ala Pro Tyr Leu 
1               5                   


<210>  15
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  15

Ser Gly Gln Ala Arg Met Phe Pro Asn Ala Pro Tyr Leu Pro Ser Cys 
1               5                   10                  15      


Leu Glu Ser 
            


<210>  16
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  16

Ser Gly Gln Ala Arg Met Phe Pro Asn Ala Pro Tyr Leu Pro Ser Cys 
1               5                   10                  15      


Leu Glu Ser Gln Pro Thr Ile 
            20              


<210>  17
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  17

Arg Pro Ala Pro Gly Ser 
1               5       


<210>  18
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  18

Pro Pro Ala His Gly Val Thr 
1               5           


<210>  19
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  19

Pro Asp Thr Arg Pro 
1               5   


<210>  20
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  20

Thr Val Cys Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys 
1               5                   10                  15      


Val Asn Phe 
            


<210>  21
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  21

Leu Ser Phe Glu Leu Leu His Ala 
1               5               


<210>  22
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  22

Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg 
1               5                   10  


<210>  23
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  23

Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr 
1               5                   10                  15      


Gly 
    


<210>  24
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  24

Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu 
1               5                   10                  15      


Arg Asp Ile Ser Thr Glu Ile Tyr 
            20                  


<210>  25
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  25

Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr 
1               5                   10                  15      


Arg Leu Phe Arg Lys 
            20      


<210>  26
<211>  36
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  26

Val Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile 
1               5                   10                  15      


Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro 
            20                  25                  30          


Asp Asp Phe Thr 
        35      


<210>  27
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic

<400>  27

Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro Thr Lys 
1               5                   10                  15      


Leu Asn Asp Leu Cys Phe Thr Asn 
            20                  


